Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Didanosine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Didanosine 125mg gastro-resistant capsules
0503010N0AAAFAF
|
Didanosine | Didanosine | Infections | No data available |
|
Didanosine 150mg dispersible chewable tablets sugar free
0503010N0AAADAD
|
Didanosine | Didanosine | Infections | No data available |
|
Didanosine 200mg dispersible chewable tablets sugar free
0503010N0AAAEAE
|
Didanosine | Didanosine | Infections | No data available |
|
Didanosine 200mg gastro-resistant capsules
0503010N0AAAGAG
|
Didanosine | Didanosine | Infections | No data available |
|
Didanosine 250mg gastro-resistant capsules
0503010N0AAAHAH
|
Didanosine | Didanosine | Infections | No data available |
|
Didanosine 25mg dispersible chewable tablets sugar free
0503010N0AAACAC
|
Didanosine | Didanosine | Infections | No data available |
|
Didanosine 400mg gastro-resistant capsules
0503010N0AAAIAI
|
Didanosine | Didanosine | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.